Ganglioglioma
| Ganglioglioma | |
|---|---|
| Other names | Gangliocytoma |
| Dysplastic cerebellar ganglioglioma (Lhermitte–Duclos disease) | |
| Specialty | Neuro-oncology |
| Usual onset | Usually childhood to young adulthood[1] |
| Treatment | Primarily surgery |
| Prognosis | >90% five-year survival rate among children[2] |
A ganglioglioma is a rare, slow-growing primary central nervous system (CNS) tumor which most frequently occurs in the temporal lobes of children and young adults.[3] They are mixed cell tumors containing both neural ganglionic cells and neural glial cell components.[4] This should not be confused with a gangliocytoma (ganglion cell tumor) which is composed of neurons of variable sizes but contains no glial cells.
- ^ "Ganglioglioma". St. Jude Children's Research Hospital. Retrieved March 8, 2023.
- ^ "Ganglioglioma". St. Jude Children's Research Hospital. Retrieved March 9, 2023.
- ^ Oppenheimer DC, Johnson MD, Judkins AR (2015). "Ganglioglioma of the Spinal Cord". Journal of Clinical Imaging Science. 5: 53. doi:10.4103/2156-7514.166355. PMC 4629305. PMID 26605127.
- ^ "Ganglioglioma | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program". rarediseases.info.nih.gov. Retrieved 14 June 2019.